TY - JOUR
KW - Humans
KW - *Valproic Acid/adverse effects/therapeutic use
KW - Female
KW - Male
KW - Adult
KW - Adolescent
KW - *Anticonvulsants/adverse effects/therapeutic use
KW - Middle Aged
KW - Young Adult
KW - *Epilepsy/drug therapy
KW - Retrospective Studies
KW - Levetiracetam/therapeutic use/adverse effects
KW - Lamotrigine/adverse effects/therapeutic use
AU - G. Mbizvo
AU - G. Martin
AU - M. Sperrin
AU - L. Bonnett
AU - P. Schofield
AU - I. Buchan
AU - G. Lip
AU - A. Marson
AD - Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
Institute of Systems, Molecular and Integrative Biology, Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.
The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.
Faculty of Biology, Division of Informatics, Imaging and Data Science, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.
University of Liverpool Department of Biostatistics, Liverpool, United Kingdom.
Department of Public Health, Policy and Systems, Institute of Population Health, University of Liverpool, Liverpool, United Kingdom.
Department of Clinical Medicine, Danish Centre for Health Services Research, Aalborg University, Aalborg, Denmark.
AN - 39208329
BT - PLoS One
DO - 10.1371/journal.pone.0306226
DP - NLM
ET - 2024/08/31
LA - eng
M1 - 8
N1 - 1932-6203
Mbizvo, Gashirai K
Orcid: 0000-0002-9588-2944
Martin, Glen P
Sperrin, Matthew
Bonnett, Laura J
Schofield, Pieta
Buchan, Iain
Orcid: 0000-0003-3392-1650
Lip, Gregory Y H
Orcid: 0000-0002-7566-1626
Marson, Anthony G
Journal Article
United States
PLoS One. 2024 Aug 29;19(8):e0306226. doi: 10.1371/journal.pone.0306226. eCollection 2024.
PY - 2024
SN - 1932-6203
EP - e0306226
T2 - PLoS One
TI - An international study to investigate and optimise the safety of discontinuing valproate in young men and women with epilepsy: Protocol
VL - 19
ER -